WCBA
WST icon

Weaver C. Barksdale & Associates’s West Pharmaceutical WST Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$9K Hold
88
– – 0.01% 303
2017
Q3 		$8K Buy
88
+4
+5% +$362 0.01% 321
2017
Q2 		$8K Sell
84
-15
-15% -$1.38K 0.01% 313
2017
Q1 		$8K Hold
99
– – 0.01% 324
2016
Q4 		$8K Buy
99
+14
+16% +$1.1K 0.01% 322
2016
Q3 		$6K Sell
85
-7
-8% -$556 0.01% 356
2016
Q2 		$7K Hold
92
– – 0.01% 316
2016
Q1 		$6K Hold
92
– – ﹤0.01% 364
2015
Q4 		$6K Sell
92
-13
-12% -$782 ﹤0.01% 358
2015
Q3 		$6K Buy
+105
New +$6.12K ﹤0.01% 358

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return